China Botanic Pharmaceutical (CBP) Reports Q2 Earnings of $0.21; Reaffirms Outlook
Tweet Send to a FriendGet Alerts CBP Hot Sheet
Trade CBP Now!
China Botanic Pharmaceutical (NYSE: CBP) reported Q2 EPS of $0.21, versus $0.19 reported last year. Revenue for the quarter came in at $23 million, versus $18.9 million reported last year.
China Botanic Pharmaceutical reaffirmed FY2012 guidance.
For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
China Botanic Pharmaceutical reaffirmed FY2012 guidance.
For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
